- 1801. Group
- [A set of patient samples in which the individuals of the group may or may not be identified. ( HL7V3.0 )] (UMLS (HL7) C1561557) =Intellectual Product =SpecimenRoleType;
| - 1851. GTSAbbreviation
- (UMLS (HL7) C1553738) =Intellectual Product =CodeSystem;
=AM;
Four times a day;
BID;
PM;
JB;
JE;
GTSAbbreviationHolidays;
three times a day at institution-specified times;
|
- 1802. Group
- [Any number of entities (members) considered as a unit. ( NCI )] (UMLS (NCI) C0441833) =Idea or Concept
| - 1852. GTSAbbreviationHolidays
- [Holidays ( HL7V3.0 )] (UMLS (HL7) C1550753) =Temporal Concept =GTSAbbreviation;
=GTSAbbreviationHolidaysUSNational;
GTSAbbreviationHolidaysChristianRoman;
|
- 1803. Group (where a specimen consists of multiple individual elements that are not individually identified)
- (UMLS (HL7) C1550036) =Idea or Concept =Specimen Role;
| - 1853. GTSAbbreviationHolidaysChristianRoman
- [Christian Holidays (Roman/Gregorian, Western Tradition.) ( HL7V3.0 )] (UMLS (HL7) C1698249) =Intellectual Product =GTSAbbreviationHolidays;
=JHCHRXME;
JHCHRXMS;
JHCHRNEW;
JHCHREAS;
JHCHRGFR;
JHCHRPEN |
- 1804. group A Streptococcus
- [species of gram-positive, coccoid bacteria isolated from skin lesions, blood, inflammatory exudates, and the upper respiratory tract of humans; it is a group A hemolytic Streptococcus that can cause scarlet fever and rheumatic fever; virulent strains penetrate deep into the body, with catastrophic results; it has been demonstrated that invasive streptococcus A infections can trigger a toxic shock syndrome, myositis, or destroy the sheath that covers the muscle, necrotizing fasciitis. ( CSP )] (UMLS (CSP) C0038411) =Bacterium =STREPTOCOCCUS;
| - 1854. GTSAbbreviationHolidaysUSNational
- [United States National Holidays (public holidays for federal employees established by U.S. Federal law 5 U.S.C. 6103). ( HL7V3.0 )] (UMLS (HL7) C1550760) =Temporal Concept =GTSAbbreviationHolidays;
=JHNUSMLK;
JHNUSPRE;
JHNUSMEM;
JHNUSMEM5;
JHNUSMEM6;
JHNUSIND;
JHNUSIND5;
JHNUSIND1;
JHNUSLBR;
JHNUSCLM;
JHNUSVET;
JHNUSTKS;
JHNUSTKS5 |
- 1805. Group A Streptococcus infection in conditions classified elsewhere and of unspecified site
- [ ] (UMLS (ICD9CM) C0374983) =Disease or Syndrome
| - 1855. GU INFECT IN PREG-UNSPEC
- [ ] (UMLS (ICD9CM) C0156756) =Disease or Syndrome
|
- 1806. Group B
- [ ] (UMLS (ICD9CM) C0348801) =Disease or Syndrome
| - 1856. GU INFECTION-DELIV W P/P
- [ ] (UMLS (ICD9CM) C0156759) =Disease or Syndrome
|
- 1807. GROUP B STREPTOC CARRIER
- (UMLS (ICD9CM) C0700297) =Finding ;
| - 1857. GU INFECTION-DELIVERED
- [ ] (UMLS (ICD9CM) C0156758) =Disease or Syndrome
|
- 1808. group B Streptococcus
- [bacterium which causes mastitis in cattle and occasionally in man; also known as Streptococcus Group B. ( CSP )] (UMLS (CSP) C0579233) =Bacterium ;
=STREPTOCOCCUS;
| - 1858. GU INFECTION-POSTPARTUM
- [ ] (UMLS (ICD9CM) C0156761) =Disease or Syndrome
|
- 1809. Group B Streptococcus infection in conditions classified elsewhere and of unspecified site
- [ ] (UMLS (ICD9CM) C0374984) =Disease or Syndrome
| - 1859. GU Irrigant
- (UMLS (HL7) C0694632) =Functional Concept =drug administration route;
|
- 1810. Group C Streptococcus infection in conditions classified elsewhere and of unspecified site
- [ ] (UMLS (ICD9CM) C0374985) =Disease or Syndrome
| - 1860. GU TB NOS-CULT DX
- [ ] (UMLS (ICD9CM) C0152846) =Disease or Syndrome
|
- 1811. group competition
- [ ] (UMLS (CSP) C0599435) =Social Behavior
| - 1861. GU TB NOS-EXAM UNKN
- [ ] (UMLS (ICD9CM) C0152844) =Disease or Syndrome
|
- 1812. group cooperation
- [ ] (UMLS (CSP) C0599436) =Social Behavior
| - 1862. GU TB NOS-HISTO DX
- [ ] (UMLS (ICD9CM) C0152847) =Disease or Syndrome
|
- 1813. group counseling
- [giving of advice and assistance for personal or psychological problems in the setting of two or more people plus a group leader; provides an opportunity for small groups of people who share common concerns and experiences to provide feedback to each other by sharing their feelings and thoughts about what someone says and does in and out of the group in a safe and supportive environment under the guidance of a group leader. ( CSP )] (UMLS (CSP) C0237547) =Therapeutic or Preventive Procedure ;
=mental health counseling;
| - 1863. GU TB NOS-MICRO DX
- [ ] (UMLS (ICD9CM) C0152845) =Disease or Syndrome
|
- 1814. Group G Streptococcus infection in conditions classified elsewhere and of unspecified site
- [ ] (UMLS (ICD9CM) C0374987) =Disease or Syndrome
| - 1864. GU TB NOS-NO EXAM
- [ ] (UMLS (ICD9CM) C0152843) =Disease or Syndrome
|
- 1815. Group Home
- [Group Home ( HL7V3.0 )] (UMLS (HL7) C0018257) =Manufactured Object; Health Care Related Organization =Institution;
| - 1865. GU TB NOS-OTH TEST
- [ ] (UMLS (ICD9CM) C0152848) =Disease or Syndrome
|
- 1816. group practice
- [Any group of three or more full-time physicians organized in a legally recognized entity for the provision of health care services, sharing space, equipment, personnel and records for both patient care and business management, and who have a predetermined arrangement for the distribution of income. ( MSH )] (UMLS (CSP) C0018262) =Health Care Related Organization ;
| - 1866. GU TB NOS-UNSPEC
- [ ] (UMLS (ICD9CM) C0374973) =Disease or Syndrome
|
- 1817. group therapy
- [form of psychotherapy in which two or more people meet with a group leader, usually a therapist; the group uses therapeutic forces within the group, interactions between members, and the interventions of the trained leader to achieve insight into the cause of problems, provide emotional suport, or effect changes in maladaptive behavior, thoughts, or feelings of the individual members. ( CSP )] (UMLS (CSP) C0033971) =Therapeutic or Preventive Procedure =psychotherapy;
| - 1867. Guabenxan
- (UMLS (NCI) C0617438) =Organic Chemical; Pharmacologic Substance ;
|
- 1818. Group therapy for psychosexual dysfunction
- [ ] (UMLS (ICD9CM) C0178063) =Therapeutic or Preventive Procedure
| - 1868. Guacetisal
- (UMLS (NCI) C0120436) =Organic Chemical; Pharmacologic Substance ;
|
- 1819. groups
- (UMLS (HL7) C1552839) =Idea or Concept =TableRules;
| - 1869. GUAIAPATE
- (UMLS (NCI) C0601166) =Organic Chemical; Pharmacologic Substance ;
|
- 1820. Growing End of Microtubule
- (UMLS (NCI) C1180021) Growing End of the Microtubule;
Plus End of Microtubule;
Plus End of the Microtubule =Cell Component ;
| - 1870. Guaifenesin-DM
- [A combination preparation containing guaifenesin and the opioid agonist dextrometorphan with expectorant and antitussive activities, respectively. Guaifenesin works by drawing water into respiratory tracts, by which reducing adhesiveness and surface tension of mucus as well as increasing hydration of mucus, thereby reducing the viscosity of mucus and making cough more productive. Dextrometorphan, a synthetic, methylated dextrorotary analogue of levorphanol, exhibits antitussive activity by activating opioid receptors in the cough center in the central nervous system, thereby raising the threshold for coughing. ( NCI )] (UMLS (NCI) C1170303) =Organic Chemical; Pharmacologic Substance ;
|
- 1821. Growth
- [A process of becoming larger or longer or more numerous. ( NCI )] (UMLS (NCI) C1457898) =Functional Concept ;
| - 1871. Guaifenesin/Codeine
- [A combination preparation containing guaifenesin and the opioid agonist codeine with expectorant and antitussive activities, respectively. Guaifenesin works by drawing water into respiratory tracts, by which reducing adhesiveness and surface tension of mucus as well as increasing hydration of mucus, thereby reducing the viscosity of mucus and making cough more productive. Codeine, a naturally occurring phenanthrene alkaloid and opioid agonist mimics the actions of opioids by binding to the opioid receptors at many sites within the central nervous system (CNS), thereby also suppressing the cough reflex by activating receptors in the cough center. ( NCI )] (UMLS (NCI) C0717642) =Organic Chemical; Pharmacologic Substance ;
|
- 1822. Growth Agents
- [signal molecules that are involved in the control of cell growth and differentiation. ( CSP )] (UMLS (NCI) C0018284) =Amino Acid, Peptide, or Protein; Biologically Active Substance =cell communication molecule;
=angiogenesis factor;
DNA Synthesis Factor;
PDGF;
IGF;
TGF;
hepatocyte growth factor;
HBGF;
hematopoietic growth factor;
connective tissue growth factor;
Neurotrophic Factor;
Anthelone U;
angiopoietin;
| - 1872. Guaimesal
- (UMLS (NCI) C0061934) =Organic Chemical; Pharmacologic Substance
|
- 1823. Growth alteration
- (UMLS (HL7) C1547214) =Intellectual Product =Tissue Type Code;
| - 1873. Guamanian
- [Denotes the inhabitants of Guam, a person from there, or their descendants elsewhere. ( NCI )] (UMLS (NCI) C0920541) =Population Group ;
=Micronesian;
|
- 1824. growth cone
- [bulbous enlargement of the growing tip of an axon during normal development or nerve regeneration; it has highly specialized chemotactic and motile functions that disappear when the end plate is formed with the target organ. ( CSP )] (UMLS (CSP) C0596632) =Cell Component ;
=axon;
| - 1874. GUANADREL
- (UMLS (NCI) C0061938) =Organic Chemical; Pharmacologic Substance =Guanidines;
[CV490] ANTIHYPERTENSIVES, OTHER =Guanadrel Sulfate;
|
- 1825. Growth Factor Antagonist Therapy
- (UMLS (NCI) C0280112) =Therapeutic or Preventive Procedure
| - 1875. Guanadrel Sulfate
- (UMLS (NCI) C0304525) =Organic Chemical; Pharmacologic Substance =GUANADREL;
=GUANADREL SULFATE 10 MG |
- 1826. Growth Factor Binding
- [Growth Factor Interaction involves temporary non-covalent binding through intermolecular physical forces of attraction and often spatial complementarity with extracellular signaling molecules (ligands) involved in the control of target cell proliferation, survival, and differentiation. ( NCI )] (UMLS (NCI) C1149299) =Molecular Function ;
| - 1876. Guanarito virus
- [ ] (UMLS (CSP) C0589088) =Virus ;
|
- 1827. Growth Factor Gene
- [Genes that code for growth factors. ( NCI )] (UMLS (NCI) C0812325) Proto-Oncogene, Growth Factor;
=Gene or Genome ;
| - 1877. guanase
- [An enzyme that catalyzes the deamination of guanine to form xanthine. EC 3.5.4.3. ( MSH )] (UMLS (CSP) C0018324) =Amino Acid, Peptide, or Protein; Enzyme
|
- 1828. Growth Factor Receptor
- [many of these are the gene products of protooncogenes (e.g. erbB, neu, fms) whose coupling is via a tyrosine kinase domain on the cytoplasmic end of the receptor molecule; postcoordinate with specific growth factor where appropriate. ( CSP )] (UMLS (NCI) C0206454) =Amino Acid, Peptide, or Protein; Receptor =Cell Surface Receptor;
=INSR;
| - 1878. Guanazole
- [A cytostatic triazole derivative antimetabolite. Guanazole scavenges tyrosine free radicals, thereby inhibiting mammalian ribonucleotide reductase activity and DNA synthesis. (NCI04) ( NCI )] (UMLS (NCI) C0018316) =Organic Chemical; Pharmacologic Substance
|
- 1829. Growth Factor Receptor Gene
- [A class of genes that encode cell surface proteins that bind to extracellular polypeptide molecules triggering intracellular signaling pathways that activate various cellular responses such as cell proliferation and/or differentiation. (NCI) ( NCI )] (UMLS (NCI) C0919511) Proto-Oncogene, Growth Factor Receptor =Gene or Genome ;
| - 1879. Guanclofine
- (UMLS (NCI) C0061941) =Organic Chemical ;
|
- 1830. Growth Factor, Recombinant Human Keratinocyte
- [A recombinant form of the endogenous human keratinocyte growth factor with cell growth promoting activity. Palifermin acts in the manner similar to the endogenous keratinocyte growth factor that binds to keratinocyte growth factor receptors on the epithelial cell surface in the lining of mouth and gastrointestinal tract. This results in stimulation of epithelial cell proliferation, differentiation and upregulation of cytoprotective mechanisms. ( NCI )] (UMLS (NCI) C0677829) =Amino Acid, Peptide, or Protein; Pharmacologic Substance
| - 1880. GUANETHIDINE
- [An antihypertensive agent that acts by inhibiting selectively transmission in post-ganglionic adrenergic nerves. It is believed to act mainly by preventing the release of norepinephrine at nerve endings and causes depletion of norepinephrine in peripheral sympathetic nerve terminals as well as in tissues. ( MSH )] (UMLS (NCI) C0018318) =Organic Chemical; Pharmacologic Substance =Guanidines;
[CV490] ANTIHYPERTENSIVES, OTHER =GUANETHIDINE MONOSULFATE |
- 1831. growth hormone deficiency
- [ ] (UMLS (CSP) C0271561) =Disease or Syndrome
| - 1881. GUANFACINE
- [A centrally acting adrenergic agonist with non-stimulant and antihypertensive property. Guanfacine selectively stimulates alpha-2 adrenergic receptors in the central nervous system, thereby resulting in inhibition of sympathetic nervous system outflow. Used alone or in combination with other drugs, this agent causes reduction of peripheral and renal vascular resistance, and lowers both systolic and diastolic blood pressure and heart rate. ( NCI )] (UMLS (NCI) C0079466) =Organic Chemical; Pharmacologic Substance =Guanidines;
phenylacetate;
[CV490] ANTIHYPERTENSIVES, OTHER;
=GUANFACINE HYDROCHLORIDE;
|
- 1832. Growth Hormone Producing Neoplasm of Pituitary
- [An adenoma or carcinoma of the anterior lobe of the pituitary gland that produces growth hormone. (NCI05) ( NCI )] (UMLS (NCI) C0278864) =Neoplastic Process
| - 1882. guanidine
- [family of iminourea derivatives which may have antiviral and antifungal properties; the parent compound is a strong organic base existing primarily as guanidium ions at physiological pH, found in the urine as a normal product of protein metabolism and also used in laboratory research as a protein denaturant. ( CSP )] (UMLS (CSP) C0018320) =Organic Chemical ;
=amidine;
=chlorhexidine;
cimetidine;
creatine;
methylguanidine;
nitrosoguanidine;
aminoguanidine;
Biguanides;
cimetidine;
Guanabenz;
GUANETHIDINE;
GUANADREL;
GUANFACINE;
Guanidine |
- 1833. Growth Hormone Producing Pituitary Gland Carcinoma
- [A rare, hormonally functioning or non-functioning pituitary gland adenocarcinoma that produces growth hormone. It may be associated with acromegaly. (NCI05) ( NCI )] (UMLS (NCI) C1334587) Malignant Growth Hormone Producing Neoplasm of Pituitary;
Malignant Growth Hormone Producing Neoplasm of Pituitary Gland;
Malignant Growth Hormone Producing Neoplasm of the Pituitary;
Malignant Growth Hormone Producing Neoplasm of the Pituitary Gland;
Malignant Growth Hormone Producing Pituitary Gland Neoplasm;
Malignant Growth Hormone Producing Pituitary Gland Tumor;
Malignant Growth Hormone Producing Pituitary Neoplasm;
Malignant Growth Hormone Producing Pituitary Tumor;
More… | - 1883. guanine analog
- [synthetic or natural chemical compounds which resemble guanine in structure and/or function. ( CSP )] (UMLS (CSP) C0596635) =Nucleic Acid, Nucleoside, or Nucleotide ;
=purine analog;
=2-Amino 6MP;
|
- 1834. growth hormone regulating factor
- [ ] (UMLS (CSP) C0596633) =Organic Chemical; Hormone
| - 1884. guanine nucleoside
- [condensation product of a guanine base plus a sugar. ( CSP )] (UMLS (CSP) C0596636) =Nucleic Acid, Nucleoside, or Nucleotide ;
=purine nucleoside;
=deoxyguanosine;
guanosine |
- 1835. growth inhibitor
- [endogenous or exogenous substances which inhibit the normal growth of animals, plants, fungi, or their tissues, or the growth of microorganisms. ( CSP )] (UMLS (CSP) C0018282) =Pharmacologic Substance; Biologically Active Substance =inhibitor/antagonist;
=Angiogenesis Antagonists | - 1885. guanine nucleotide
- [phosphate ester of a guanine nucleoside, particularly the 5'-phosphate of guanine in N-glycosidic linkage with ribose or deoxyribose as occurs in nucleic acid. ( CSP )] (UMLS (CSP) C0018328) =Nucleic Acid, Nucleoside, or Nucleotide =purine nucleotide;
=GDP;
GTP;
GMP |
- 1836. growth/development
- [includes normal and pathological, biological and psychological, age-related changes; includes the entire life span and may be used for any species. ( CSP )] (UMLS (CSP) C0018271) =Physiologic Function ;
=Biologic;
=aging;
cell cycle;
embryology;
life cycle;
meiosis;
metamorphosis;
dental development;
Plasticity/Regeneration/Transplantation;
child physical development;
developmental nutrition;
Developmental Process, Multicellular;
microorganism growth;
ecdysis;
auxotrophy;
connective tissue development;
plant development;
reproductive development;
tissue tropism;
| - 1886. guanine nucleotide binding protein
- [family of GTP-, GDP-, and GMP-binding proteins; do not confuse with G PROTEINs, which are a subset of the family. ( CSP )] (UMLS (CSP) C0596637) =Amino Acid, Peptide, or Protein; Biologically Active Substance =binding protein;
=tubulin;
G protein;
translation factor;
|
- 1837. Gs
- [Supernumerary maxillary left lateral primary incisor ( HL7V3.0 )] (UMLS (HL7) C1552152) =Body Part, Organ, or Organ Component =SUPERNUMERARY TEETH;
| - 1887. Guanoclor
- (UMLS (NCI) C0061964) =Organic Chemical; Pharmacologic Substance
|
- 1838. GS-0840
- (UMLS (NCI) C0540692) =Organic Chemical; Pharmacologic Substance ;
| - 1888. guanosine
- [purine nucleoside that has guanine linked by its N9 nitrogen to the C1 carbon of ribose; a component of ribonucleic acid; its nucleotides play important roles in metabolism. ( CSP )] (UMLS (CSP) C0018330) =Nucleic Acid, Nucleoside, or Nucleotide; Pharmacologic Substance; Biologically Active Substance =ribonucleoside;
guanine nucleoside |
- 1839. GS7904L
- (UMLS (NCI) C1328713) =Organic Chemical; Pharmacologic Substance ;
| - 1889. guanyl cyclase
- [Guanylate cyclase (GC) is an enzyme that converts GTP to the second messenger cyclic GMP (cGMP). There are two forms: plasma membrane GCs that are receptors for hormones, and intracellular soluble GCs that are activated by the gaseous second messenger nitric oxide (NO). EC 4.6.1.2 ( NCI )] (UMLS (CSP) C0018358) =Amino Acid, Peptide, or Protein; Enzyme ;
=phosphorus oxygen lyase;
|
- 1840. GSPE
- [An oligomeric proanthocyanidin extracted from grape seeds. IH636 grape seed proanthocyanidin extract exhibits dose-dependent free-radical scavenging and antioxidant properties. ( NCI )] (UMLS (NCI) C0967935) IH636 Grape Seed Proanthocyanidin Extract =Organic Chemical; Pharmacologic Substance ;
| - 1890. guanylate
- [ ] (UMLS (CSP) C0598546) =Nucleic Acid, Nucleoside, or Nucleotide ;
|
- 1841. GSTR/DDNTS NOS W HMRHG
- [ ] (UMLS (ICD9CM) C0156082) =Disease or Syndrome ;
| - 1891. Guanylate Cyclase 1, Soluble, Alpha 2 Gene
- [This gene plays a role in GTP metabolism and nitric oxide-mediated signal transduction. ( NCI )] (UMLS (NCI) C1415359) GUCY1A2;
GUCY1A2 Gene =Gene or Genome |
- 1842. GSTR/DDNTS NOS W/O HMRHG
- [ ] (UMLS (ICD9CM) C0156081) =Disease or Syndrome
| - 1892. Guanylate Cyclase 1, Soluble, Alpha 3 Gene
- [This gene is involved in the metabolism of GTP and nitric oxide-mediated signal transduction. ( NCI )] (UMLS (NCI) C1415360) GUCY1A3;
GUCY1A3 Gene =Gene or Genome |
- 1843. GT
- [Central American country south of Mexico bordering on the Pacific and the Caribbean, capital city is Guatemala City. ( CSP )] (UMLS (NCI) C0018367) =Geographic Area =Central America;
| - 1893. Guanylate Cyclase 1, Soluble, Beta 2 Gene
- [This gene plays a role in the metabolism of GTP. It is also involved in nitric oxide-mediated signal transduction in the cardiovascular system. ( NCI )] (UMLS (NCI) C1415361) GUCY1B2;
GUCY1B2 Gene =Gene or Genome |
- 1844. GTF2A1
- [Encoded by human GTF2A1 Gene, TFIIA Alpha p55 is a 55-kDa post-translationally processed precursor of the 35-kD alpha (N-terminal) and 19-kD beta (C-terminal) subunits of general transcription initiation factor TFIIA. These subunits and the 12-kDa gamma subunit (GTF2A2 Gene) form a six strand beta-barrel that interacts with TBP and a separate four-helix bundle positioned just upstream of the TBP-TATA complex. Accurate transcription initiation on class II genes involves ordered assembly of RNA polymerase II and general initiation factors. (NCI) ( NCI )] (UMLS (NCI) C1336610) TFIIA Alpha p55;
=Amino More… | - 1894. Guanylate Cyclase 1, Soluble, Beta 3 Gene
- [This gene is involved in the metabolism of GTP. It also plays a role in nitric oxide-mediated signal transduction in the cardiovascular system. ( NCI )] (UMLS (NCI) C1415362) GUCY1B3;
GUCY1B3 Gene =Gene or Genome |
- 1845. GTF2D
- [The TATA Binding Protein (TBP) is a DNA-binding component of the TFIID basal transcription factor of the class II genes (transcribed by RNA polymerase II), the TFIIIB class III transcription factor, and the TIF-1B (SL1) class I factor. Its name is derived from the A-T rich DNA motif that it binds to in the class II genes, most commonly TATAAAA. ( NCI )] (UMLS (NCI) C0144555) =Amino Acid, Peptide, or Protein; Biologically Active Substance ;
| - 1895. Guanylate Cyclase, Soluble
- [Human Soluble Guanylate Cyclases (Adenylyl Cyclase 4/Guanylyl Cyclase Family) are heterodimeric (alpha/beta) nitric oxide-activated cytoplasmic enzymes that catalyze conversion of GTP to cGMP second messenger. The main receptors for nitric oxide in the cardiovascular system and for nitrovasodilator drugs, alpha/beta interaction is required for guanylyl cyclase activity. (NCI) ( NCI )] (UMLS (NCI) C1097411) GUCY;
sGC;
Soluble Guanylate Cyclase;
Soluble Guanylyl Cyclase;
=Amino Acid, Peptide, or Protein; Enzyme; Receptor |
- 1846. GTI-2040
- [A 20-mer antisense oligonucleotide complementary to a coding region in the mRNA of the R2 small subunit component of human ribonucleotide reductase. GTI-2040 decreases mRNA and protein levels of R2 in vitro and may inhibit tumor cell proliferation in human tumors in vivo. (NCI04) ( NCI )] (UMLS (NCI) C1142995) =Nucleic Acid, Nucleoside, or Nucleotide; Pharmacologic Substance ;
| - 1896. guanylhydrazine
- [ ] (UMLS (CSP) C0597828) =Organic Chemical
|
- 1847. GTP
- [guanosine 5'-(tetrahydrogen triphosphate); a guanine nucleotide containing three phosphate groups esterified to the sugar moiety. ( CSP )] (UMLS (NCI) C0018353) =Nucleic Acid, Nucleoside, or Nucleotide; Biologically Active Substance ;
=guanine nucleotide;
nucleoside triphosphate | - 1897. Guarantor
- (UMLS (HL7) C1548604) =Intellectual Product =Disabled Person Code;
◊ (UMLS (HL7) C1549447) Idea or Concept Mail Claim Party; |
- 1848. GTP Binding
- [GTP Binding is a molecular interaction between specific proteins (containing a GTP binding site) and guanosine 5-prime triphosphate during diverse cellular processes, such as RNA synthesis, translation, signal transduction, and cytoskeletal assembly. ( NCI )] (UMLS (NCI) C1149035) =Molecular Function ;
| - 1898. Guarantor
- [An individual or organization that makes or gives a promise, assurance, pledge to pay or has paid the healthcare service provider. ( HL7V3.0 )] (UMLS (HL7) C1555598) =Intellectual Product =RoleCode;
|
- 1849. GTP phosphohydrolase
- [nonEC; family of high energy phosphate hydrolases; unlike ATPases, which are mainly involved in bioenergetics, GTPases are mainly involved in biological signal transduction. ( CSP )] (UMLS (CSP) C0018296) =Amino Acid, Peptide, or Protein; Enzyme =acid anhydride hydrolase;
=dephosphin | - 1899. Guarantor Credit Rating Code
- (UMLS (HL7) C1547736) =Intellectual Product =HL7 Vocabulary Version 2.5;
|
- 1850. GTPase Gene
- [Genes (superfamily) that encode GTP hydrolyzing enzymes, which cycle between the GDP-bound inactive state and the GTP-bound active state acting as intracellular switches in various cellular pathways, such as signal transduction. (NCI) ( NCI )] (UMLS (NCI) C1333729) =Gene or Genome ;
| - 1900. Guarantor external identifier
- (UMLS (HL7) C1549703) =Idea or Concept =Identifier type;
|
home
